NEWS

RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company

New Fund Participates in Series A Financing for URI-Based MindImmune, Developer of a Novel Treatment for Neuroinflammatory Conditions Such as Alzheimer’s Disease

Read More

Arctura Awarded $1.15 Million Grant from U.S. Dept. of Energy

Arctura has won a $1.15-million Phase IIB SBIR grant from the U.S. Department of Energy (DOE) to commercialize a new blade coating designed to reduce the damage to wind turbine blades caused by lightning.

Read More

Slater-Backed Company Acquired by Novartis

The Slater Technology Fund, Rhode Island’s oldest and most active seed-stage investment fund, applauds the team at Cadent Therapeutics, who today announced that the company has entered into an agreement to be acquired by global healthcare giant Novartis [NYSE: NVS] in a deal worth up to $770 million. 

Read More